H.C. Wainwright Reiterates Buy Rating on Solid Biosciences (SLDB)

September 14, 2026 7:34 AM

H.C. Wainwright analyst Arthur He reiterated a Buy rating and $25.00 price target on Solid Biosciences (NASDAQ: SLDB).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found